Hosted on MSN1mon
Biohaven's troriluzole gains FDA priority review for SCASCA, a rare and life-threatening neurodegenerative ... analysis and 8 additional key insights about Biohaven's financial health and market position. Biohaven's clinical development program for ...
Screenings are aimed at preventing sudden cardiac arrest (SCA), the leading cause of death among student-athletes ...
SCA is a serious condition where the heart suddenly stops beating. It can be deadly and is responsible for many heart-related ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results